Evidence map›Paper›PMID 42088503›Full record

ArticleFrontiers in immunology2026

Caffeine-mediated CD39

Liangyu Zhu, Zida Zheng, Xun Huang, Haoran Lu, Zhiqiang Chen, Hanxin Wu, Li Peng, Lvyan Tao, Yue Bai, Rui Yang and 8 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Liangyu ZhuDepartment of Pathogen Biology and Immunology and Department of Biochemistry and Molecular Biology, Faculty of Basic Medical Sciences, Kunming Medical University, Kunming, China.
Zida ZhengDepartment of Pathogen Biology and Immunology and Department of Biochemistry and Molecular Biology, Faculty of Basic Medical Sciences, Kunming Medical University, Kunming, China.
Xun HuangDepartment of Pathogen Biology and Immunology and Department of Biochemistry and Molecular Biology, Faculty of Basic Medical Sciences, Kunming Medical University, Kunming, China.
Haoran LuDepartment of Pathogen Biology and Immunology and Department of Biochemistry and Molecular Biology, Faculty of Basic Medical Sciences, Kunming Medical University, Kunming, China.
Zhiqiang ChenDepartment of Pathogen Biology and Immunology and Department of Biochemistry and Molecular Biology, Faculty of Basic Medical Sciences, Kunming Medical University, Kunming, China.
Hanxin WuDepartment of Pathogen Biology and Immunology and Department of Biochemistry and Molecular Biology, Faculty of Basic Medical Sciences, Kunming Medical University, Kunming, China.
Li PengDepartment of Pathogen Biology and Immunology and Department of Biochemistry and Molecular Biology, Faculty of Basic Medical Sciences, Kunming Medical University, Kunming, China.
Lvyan TaoDepartment of Pathogen Biology and Immunology and Department of Biochemistry and Molecular Biology, Faculty of Basic Medical Sciences, Kunming Medical University, Kunming, China.
Yue BaiDepartment of Pathogen Biology and Immunology and Department of Biochemistry and Molecular Biology, Faculty of Basic Medical Sciences, Kunming Medical University, Kunming, China.
Rui YangDepartment of Pathogen Biology and Immunology and Department of Biochemistry and Molecular Biology, Faculty of Basic Medical Sciences, Kunming Medical University, Kunming, China.
Ruian BaoDepartment of Pathogen Biology and Immunology and Department of Biochemistry and Molecular Biology, Faculty of Basic Medical Sciences, Kunming Medical University, Kunming, China.
Suyi LuoDepartment of Pathogen Biology and Immunology and Department of Biochemistry and Molecular Biology, Faculty of Basic Medical Sciences, Kunming Medical University, Kunming, China.
Weijiang MaDepartment of Pathogen Biology and Immunology and Department of Biochemistry and Molecular Biology, Faculty of Basic Medical Sciences, Kunming Medical University, Kunming, China.
Jieqin SongDepartment of Pathogen Biology and Immunology and Department of Biochemistry and Molecular Biology, Faculty of Basic Medical Sciences, Kunming Medical University, Kunming, China.
Jiaomei TangDepartment of Pathogen Biology and Immunology and Department of Biochemistry and Molecular Biology, Faculty of Basic Medical Sciences, Kunming Medical University, Kunming, China.
Bingxue LiDepartment of Pathogen Biology and Immunology and Department of Biochemistry and Molecular Biology, Faculty of Basic Medical Sciences, Kunming Medical University, Kunming, China.
Fukai BaoDepartment of Pathogen Biology and Immunology and Department of Biochemistry and Molecular Biology, Faculty of Basic Medical Sciences, Kunming Medical University, Kunming, China.
Aihua LiuDepartment of Pathogen Biology and Immunology and Department of Biochemistry and Molecular Biology, Faculty of Basic Medical Sciences, Kunming Medical University, Kunming, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The global impact of pulmonary tuberculosis (PTB) is compounded by a limited understanding of modifiable risk factors. While caffeine is the most consumed psychoactive substance, its causal relationship with PTB and the underlying immunological mechanisms remain unknown. Methods: A three-tiered approach was used: 1) two-sample Mendelian randomization (TSMR) was used to analyze 486 metabolites and 731 immune cells for PTB causality (inverse variance weighting was the primary method with reverse MR and Bonferroni correction), 2) single-cell RNA sequencing (scRNA-seq) and bulk RNA-seq were integrated (Seurat, Gene set enrichment analysis, and pseudotime analysis) to characterize CD39 Results: Based on TSMR, eight metabolites (including caffeine) and nine immune subsets (including activated CD4 Conclusions: We first identified a causal association between genetically predicted caffeine levels and PTB risk at the genetic level. We further uncovered a CD39-adenosine-based Treg activation mechanism underlying this association, and identified PSMC5 as a potential therapeutic target for host-directed therapy. These findings inform PTB pathogenesis and host-directed therapy.

Indexed as

Antigens, CDApyraseCaffeineLymphocyte ActivationReceptors, Purinergic P1T-Lymphocytes, RegulatoryTuberculosis, PulmonaryAnimalsFemaleHumansMiceMycobacterium tuberculosisQuantitative Trait LociRisk FactorsSignal TransductionAntigens, CDApyraseCaffeineCD39 antigenENTPD1 protein, humanReceptors, Purinergic P1adenosine receptorcaffeineeQTLmendelian randomizationpulmonary tuberculosisTregs

Identifiers

PMID42088503
PMCPMC13135997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.